Saturday, October 31, 2026

EUR/CHF Is 1% Up In The Last 5 Sessions

ViaNews Editorial Team

November 4, 2023

EUR/CHF Is 1% Up In The Last 5 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.14% for the last 5 sessions. At 11:06 EST on Saturday, 4 November, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 2.368% up from its 52-week low and 4.526% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a positive 0.24%, a negative 0.05%, and a positive 0.26%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.44% (last week), 0.30% (last month), and 0.26% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be oversold (<=20).

News about

  • According to FXStreet on Friday, 3 November, "Given our house view that a US slowdown is more likely in the next quarter rather than this one, we therefore expect EUR/USD to end the year around this 1.05/1.06 area and USD/JPY to end the year not far from 150. "
  • According to FXStreet on Thursday, 2 November, "This would normally be a weak environment for the Yen as well, meaning that we cannot rule out USD/JPY retesting 152."
  • According to FXStreet on Thursday, 2 November, "(This story was corrected on November 2 at 07:17 GMT and 07:49 to say that the US Dollar was the weakest against the Swiss Franc and the USD/JPY was trading below 150.50 instead of 105.50)."
  • Usd/jpy corrects further from YTD top, slides to 150.00 neighbourhood amid USD selling bias. According to FXStreet on Thursday, 2 November, "Furthermore, a generally positive risk tone could dent the JPY's safe-haven demand and lend some support to the USD/JPY pair, warranting some caution for aggressive bearish traders.", "The USD/JPY pair extends the overnight retracement slide from the 151.70 area, or its highest level since October 2022 and drifts lower for the second successive day on Thursday. "
  • Usd/jpy technical analysis: it May maintain its gains until Japanese intervention - 02 November 2023. According to DailyForex on Thursday, 2 November, "The USD/JPY currency pair will remain on its upward path until there is Japanese intervention in the markets. ", "Our technical view of the performance of the USD/JPY currency pair remains unchanged. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com